Elemer Piros

Stock Analyst at Rodman & Renshaw

(3.04)
# 2,391
Out of 4,851 analysts
110
Total ratings
36.54%
Success rate
2.12%
Average return

Stocks Rated by Elemer Piros

BioXcel Therapeutics
Mar 19, 2025
Initiates: Buy
Price Target: $65
Current: $1.53
Upside: +4,148.37%
FibroBiologics
Dec 12, 2024
Initiates: Buy
Price Target: $12
Current: $0.85
Upside: +1,312.10%
Tharimmune
Dec 6, 2024
Initiates: Buy
Price Target: $17
Current: $1.58
Upside: +975.95%
Quince Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $11
Current: $1.09
Upside: +909.17%
Monopar Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $50
Current: $35.59
Upside: +40.49%
MIRA Pharmaceuticals
Sep 30, 2024
Initiates: Buy
Price Target: $17
Current: $1.40
Upside: +1,114.29%
Athira Pharma
Aug 19, 2024
Initiates: Buy
Price Target: $22
Current: $0.33
Upside: +6,669.23%
Cassava Sciences
Aug 8, 2024
Reiterates: Buy
Price Target: $107
Current: $2.15
Upside: +4,876.74%
Cognition Therapeutics
Jul 2, 2024
Reiterates: Buy
Price Target: $14
Current: $0.31
Upside: +4,451.37%
Annovis Bio
Jul 2, 2024
Reiterates: Buy
Price Target: $67
Current: $3.24
Upside: +1,967.90%
Initiates: Buy
Price Target: $43
Current: $2.45
Upside: +1,655.10%
Initiates: Buy
Price Target: $18
Current: $5.71
Upside: +215.24%
Maintains: Buy
Price Target: $12$7.5
Current: $1.53
Upside: +390.20%
Reiterates: Buy
Price Target: $15
Current: $2.47
Upside: +507.29%
Reiterates: Buy
Price Target: $21
Current: $7.65
Upside: +174.51%
Reiterates: Buy
Price Target: $38
Current: $4.52
Upside: +740.71%
Reiterates: Buy
Price Target: $40
Current: $0.91
Upside: +4,285.96%
Reiterates: Buy
Price Target: $5
Current: $0.78
Upside: +545.16%
Reiterates: Buy
Price Target: $114
Current: $8.58
Upside: +1,228.67%
Maintains: Buy
Price Target: $260$200
Current: $4.02
Upside: +4,875.12%
Reiterates: Buy
Price Target: $23
Current: $3.41
Upside: +574.49%
Reiterates: Buy
Price Target: $33
Current: $12.43
Upside: +165.49%
Downgrades: Sell
Price Target: $40
Current: $18.51
Upside: +116.10%
Upgrades: Buy
Price Target: $40
Current: $0.72
Upside: +5,437.10%
Initiates: Buy
Price Target: $37
Current: $1.77
Upside: +1,996.32%
Maintains: Buy
Price Target: $38$32
Current: $4.24
Upside: +654.72%
Downgrades: Sell
Price Target: $77
Current: $12.26
Upside: +528.06%
Initiates: Buy
Price Target: $70
Current: $0.58
Upside: +12,010.73%
Downgrades: Neutral
Price Target: n/a
Current: $8.47
Upside: -
Maintains: Neutral
Price Target: $24$50
Current: $16.74
Upside: +198.69%
Assumes: Overweight
Price Target: $33
Current: $2.47
Upside: +1,236.03%
Upgrades: Overweight
Price Target: n/a
Current: $9.88
Upside: -
Initiates: Overweight
Price Target: $26
Current: $3.34
Upside: +678.44%
Initiates: Overweight
Price Target: $28
Current: $132.03
Upside: -78.79%
Maintains: Overweight
Price Target: $525$850
Current: $6.44
Upside: +13,098.76%
Maintains: Overweight
Price Target: $35$21
Current: $8.40
Upside: +150.15%